Metabolism and Excretion of [14C]CC-90001 in Healthy Male Subjects

Summary

This is a clinical pharmacology study to characterize the biotransformation and excretion of \[14C\]CC-90001 and to evaluate the safety and tolerability of \[14C\]CC-90001 following a single oral dose of \[14C\]CC-90001 in healthy male subjects. Approximately 8 subjects will be enrolled into the study with a goal of 6 subjects being eligible for analysis.

Timeline

Start

2020-12-16

Primary completion

2021-03-11

Completion

2021-03-11

Drugs

Indications

No indication recorded.